United States Gene Therapy Market Assessment, By Type [Gene Augmentation, Gene Silencing, Others], By Vector [Viral Vectors, Non-Viral Vectors], By Gene Delivery Method [In vivo, Ex vivo], By Application [Oncological Diseases, Genetic Diseases, Cardiovasc

United States Gene Therapy Market Assessment, By Type [Gene Augmentation, Gene Silencing, Others], By Vector [Viral Vectors, Non-Viral Vectors], By Gene Delivery Method [In vivo, Ex vivo], By Application [Oncological Diseases, Genetic Diseases, Cardiovascular Diseases, Neuromuscular Diseases, Hematological Diseases, Infectious Diseases, Others], By Route of Administration [Intravenous, Others], By End-user [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F



Saudi Arabia spine surgery market is projected to witness a CAGR of 5.06% during the forecast period 2024-2031, growing from USD 357.56 million in 2023 to USD 505.21 million in 2031. The expansion of the geriatric population boosts the market’s growth, the increasing popularity of minimally invasive spine surgeries, and rising investments by the government towards the upgradation of healthcare infrastructure in the country. The demand for spine surgery devices is also anticipated to increase because of investments made in cutting-edge healthcare infrastructure and the influx of medical tourists in Saudi Arabia.

Additionally, the increasing emphasis on ensuring the provision of high-quality medical equipment and procedures to improve patient outcomes is also bolstering the Saudi Arabia spine surgery market. In May 2023, Dallah Hospital Al-Nakheel announced that they had successfully treated different cases where patients were living with spinal deformities, including a 14-year-old with severe scoliosis and cerebral palsy. They conducted surgery, which lasted four hours, to adjust and straighten the spine efficiently and quickly, after which the patient was able to function independently and was discharged four days later. The Dallah Health Group serves over 1.5 million patients annually with its 500 outpatient clinics and employs around 1000 specialists and more than 3000 employees to provide high-quality care to their patients.

Saudi Arabia’s healthcare system is rapidly expanding as more and more foreign businesses set up clinics and research facilities in the country. The Saudi Arabia spine surgery market is also expected to witness growth in the coming years due to the rising prevalence of spine injuries caused by an increasing number of car accidents. This, in turn, is propelling the requirement for sophisticated surgical procedures for treating patients with spine fractures and dislocations, among other trauma-related injuries.

Geriatric Population’s Expansion Supports Market Growth

The expansion of the geriatric population in the country is expected to bolster the Saudi Arabia spine surgery market growth as they are more susceptible to various age-related spinal disorders and spine injuries. According to the Saudi Arabian Monetary Agency (SAMA) estimates, 25% of the total population of 40 million will be sixty or older by the end of 2050. Additionally, about 4% of the total population, or 1.6 million individuals, will be eighty or older by the end of 2050. This increase is expected to propel the market demand as the older population is at a greater risk of degenerative disc disease, among others.

Increasing Research Activities Supports Market Expansion

Over the past few decades, the focus on spine surgery research has significantly increased in Saudi Arabia, suggesting a rising emphasis on upgradation of spine surgical techniques in the country. The increase in research output can be attributed to a greater desire to improve both the volume and quality of spine procedures carried out in Saudi Arabia. The country is demonstrating a commitment to improving patient outcomes and healthcare standards in the field of spinal interventions by advancing spine surgery research, to become a premier hub for advanced medical treatments and a leading destination for medical tourism. According to an article published in the JOURNAL of SPINE PRACTICE in July 2023, an increase of 41% in the number of spine surgery-related publications was witnessed over the last decade in Saudi Arabia.

Minimally Invasive Surgeries Expected to Grow

The growing popularity of minimally invasive spine surgeries can be attributed to increasing hospital investments towards minimally invasive surgical tools, state of the art equipment, and advanced imaging modalities. Injuries and disorders affecting the spinal framework can result in function impairment and severe pain and range from spinal stenosis and herniated discs to complex conditions such as degenerative disc disease and scoliosis. Spine surgeries aid in stabilizing the spine, alleviating pain, and restoring functionality, thus various hospitals and healthcare organizations are actively investing in improving the quality of care provided to patients for enhancing patient outcomes. Additionally, the growing awareness about the different advantages associated with minimally invasive spine surgeries such as reduced blood loss and risk of infection is further supporting the segment’s growth.

Hospitals Hold Major Market Share

The segment’s growth is supported by the rising investments by hospitals to ensure the provision of advanced equipment and techniques to address the growing requirement for spine surgeries in Saudi Arabia. In November 2023, Dr. Soliman Fakeeh Hospital (DSFH), Jeddah announced that they had successfully treated their first patient with two-level lumbar canal stenosis with the help of Unilateral Biportal Endoscopic (UBE) spine surgery. The technique gained popularity in recent years and is widely used for treating thoracic, cervical, and lumbar degenerative diseases. These introductions are being made by the hospitals in the country in an effort to provide advanced medical care to their patients, in order to improve treatment outcomes.

Future Market Scenario (2024-2031F)

As per the Saudi Arabia spine surgery market analysis, the market is expected to witness significant growth in the coming years due to the rising investments by the government towards the upgradation of country’s healthcare infrastructure. Under Vision 2030, the government plans on investing USD 65 billion towards Saudi Arabia’s healthcare infrastructure. They also aim to boost the contribution of the private sector to 65% by 2030, with the privatization of 2,300 primary health centers and 290 hospitals. The Ministry of Health (MOH) also plans on launching health clusters across different regions in Saudi Arabia to improve access to healthcare services and promote integrated and preventive care. Such measures coupled with the growing awareness about the negative effects associated with spine injuries and disorders and the availability of different surgical interventions are expected to provide lucrative growth opportunities to the market.

Key Players Landscape and Outlook

The rising investments by the key players of the market in mergers and acquisitions are expected to provide lucrative growth opportunities for the market in the coming years. In September 2023, Globus Medical, Inc. concluded the previously announced merger with NuVasive, known for developing medical devices that support minimally invasive procedures. The merger is expected to aid the companies in combining their differentiated portfolios and reach customers globally while ensuring that advanced orthopedic and spine care is provided to them. The merger is also expected to provide a robust financial foundation for generating value and better opportunities for increased revenue.


1. Project Scope and Definitions
2. Research Methodology
3. Executive Summary
4. United States Gene Therapy Market Outlook, 2017-2031F
4.1. Market Size Analysis & Forecast
4.1.1. By Value
4.1.2. By Volume
4.2. Market Share Analysis & Forecast
4.2.1. By Type
4.2.1.1. Gene Augmentation
4.2.1.2. Gene Silencing
4.2.1.3. Others
4.2.2. By Vector
4.2.2.1. Viral Vectors
4.2.2.2. Non-Viral Vectors
4.2.3. By Gene Delivery Method
4.2.3.1. In vivo
4.2.3.2. Ex vivo
4.2.4. By Application
4.2.4.1. Oncological Diseases
4.2.4.2. Genetic Diseases
4.2.4.3. Cardiovascular Diseases
4.2.4.4. Neuromuscular Diseases
4.2.4.5. Hematological Diseases
4.2.4.6. Infectious Diseases
4.2.4.7. Others
4.2.5. By Route of Administration
4.2.5.1. Intravenous
4.2.5.2. Others
4.2.6. By End-user
4.2.6.1. Hospitals
4.2.6.2. Cancer and Research Institutes
4.2.6.3. Clinics
4.2.6.4. Others
4.2.7. By Region
4.2.7.1. Northeast
4.2.7.2. Midwest
4.2.7.3. West
4.2.7.4. South
4.2.8. By Company Market Share Analysis (Top 5 Companies and Others – By Value, 2023)
4.3. Market Map Analysis, 2023
4.3.1. By Type
4.3.2. By Vector
4.3.3. By Gene Delivery Method
4.3.4. By Application
4.3.5. By Route of Administration
4.3.6. By End-user
4.3.7. By Region
5. Demand Supply Analysis
6. Import and Export Analysis
7. Value Chain Analysis
8. Porter’s Five Forces Analysis
9. PESTLE Analysis
10. Pricing Analysis
11. Market Dynamics
11.1. Market Drivers
11.2. Market Challenges
12. Market Trends and Developments
13. Regulatory Framework and Innovation
13.1. Clinical Trials
13.2. Regulatory Approvals
14. Patent Landscape
15. Case Studies
16. Competitive Landscape
16.1. Competition Matrix of Top 5 Market Leaders
16.2. SWOT Analysis for Top 5 Players
16.3. Key Players Landscape for Top 10 Market Players
16.3.1. Gilead Sciences Inc. (Kite Pharma)
16.3.1.1. Company Details
16.3.1.2. Key Management Personnel
16.3.1.3. Products and Services
16.3.1.4. Financials (As Reported)
16.3.1.5. Key Market Focus and Geographical Presence
16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
16.3.2. Bristol-Myers Squibb Company
16.3.3. Amgen, Inc.
16.3.4. Sarepta Therapeutics, Inc.
16.3.5. F. Hoffmann-la Roche ltd. (Spark Therapeutics, Inc.)
16.3.6. Bluebird Bio, Inc.
16.3.7. Novartis AG
16.3.8. CSL Behring LLC (Manufactured by uniQure Inc.)
16.3.9. Johnson & Johnson Services, Inc. (Janssen Research & Development, LLC)
16.3.10. CRISPR Therapeutics AG
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
17. Strategic Recommendations
18. About Us and Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings